Barely Significant
← all excerpts

Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis.

Ann Hematol · 2023 · PMC9919741 · PMID 36773040

1
hedged sentence
closest p
boldest claim

The sentences

a nonsignificant trendno p-value reported
Another retrospective study suggested a survival benefit of dexamethasone as well, and although the reduction of relapse risk appeared to be its main driver in that report, a nonsignificant trend toward a reduced early death rate was also observed [ 24 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.